Does Siegfried Holding (VTX:SFZN) Deserve A Spot On Your Watchlist?
Oct 26
Have your own idea? Try our Stock Screener
Swiss (SMI) Life Sciences Industry Analysis
UpdatedOct 29, 2025
DataAggregated Company Financials
Companies7
- 7D2.0%
- 3M-4.7%
- 1Y-4.1%
- YTD0.3%
The Life Sciences industry is up 4.5% in the last week, with Lonza Group up 4.6%. In the past year, the industry is down 3.7%. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Swiss Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 Oct 2025 | CHF 51.8b | CHF 10.6b | CHF 1.1b | 31x | 47.1x | 4.9x |
| Fri, 26 Sep 2025 | CHF 48.2b | CHF 10.6b | CHF 1.1b | 31.3x | 43.8x | 4.5x |
| Sun, 24 Aug 2025 | CHF 53.7b | CHF 10.7b | CHF 1.1b | 36.5x | 48.7x | 5x |
| Tue, 22 Jul 2025 | CHF 53.1b | CHF 10.1b | CHF 1.0b | 33x | 51.1x | 5.3x |
| Thu, 19 Jun 2025 | CHF 52.5b | CHF 10.1b | CHF 1.0b | 33.3x | 50.5x | 5.2x |
| Sat, 17 May 2025 | CHF 53.3b | CHF 10.1b | CHF 1.0b | 32.9x | 51.3x | 5.3x |
| Mon, 14 Apr 2025 | CHF 48.0b | CHF 10.1b | CHF 1.0b | 28.1x | 46.8x | 4.8x |
| Wed, 12 Mar 2025 | CHF 51.1b | CHF 10.1b | CHF 1.0b | 28.7x | 48.9x | 5x |
| Fri, 07 Feb 2025 | CHF 58.6b | CHF 10.1b | CHF 1.0b | 36.7x | 58.2x | 5.8x |
| Sun, 05 Jan 2025 | CHF 52.7b | CHF 10.2b | CHF 943.5m | 36x | 55.8x | 5.2x |
| Tue, 03 Dec 2024 | CHF 53.4b | CHF 10.2b | CHF 943.7m | 40.8x | 56.6x | 5.2x |
| Thu, 31 Oct 2024 | CHF 54.5b | CHF 10.2b | CHF 943.4m | 41.8x | 57.8x | 5.3x |
| Sat, 28 Sep 2024 | CHF 55.9b | CHF 10.2b | CHF 943.4m | 43.2x | 59.3x | 5.5x |
| Mon, 26 Aug 2024 | CHF 58.1b | CHF 10.2b | CHF 936.8m | 45.6x | 62x | 5.7x |
| Wed, 24 Jul 2024 | CHF 55.4b | CHF 10.3b | CHF 1.0b | 48x | 55.3x | 5.4x |
| Fri, 21 Jun 2024 | CHF 51.7b | CHF 10.3b | CHF 1.0b | 44.4x | 51.5x | 5x |
| Sun, 19 May 2024 | CHF 56.1b | CHF 10.3b | CHF 1.0b | 46x | 56x | 5.5x |
| Tue, 16 Apr 2024 | CHF 55.9b | CHF 10.3b | CHF 1.0b | 44.2x | 55.7x | 5.4x |
| Thu, 14 Mar 2024 | CHF 52.5b | CHF 10.2b | CHF 1.0b | 44.5x | 52.3x | 5.1x |
| Sat, 10 Feb 2024 | CHF 48.1b | CHF 10.2b | CHF 1.0b | 42.5x | 47.2x | 4.7x |
| Mon, 08 Jan 2024 | CHF 40.2b | CHF 9.8b | CHF 1.5b | 30.7x | 26.9x | 4.1x |
| Wed, 06 Dec 2023 | CHF 39.4b | CHF 9.8b | CHF 1.5b | 28.9x | 26.4x | 4x |
| Fri, 03 Nov 2023 | CHF 37.8b | CHF 9.8b | CHF 1.5b | 26.4x | 25.3x | 3.9x |
| Sun, 01 Oct 2023 | CHF 46.5b | CHF 9.8b | CHF 1.5b | 32.2x | 31.2x | 4.8x |
| Tue, 29 Aug 2023 | CHF 52.0b | CHF 9.8b | CHF 1.5b | 36x | 34.8x | 5.3x |
| Thu, 27 Jul 2023 | CHF 52.3b | CHF 9.8b | CHF 1.5b | 35.8x | 33.8x | 5.3x |
| Sat, 24 Jun 2023 | CHF 55.2b | CHF 9.7b | CHF 1.6b | 34.3x | 33.7x | 5.7x |
| Mon, 22 May 2023 | CHF 60.8b | CHF 9.7b | CHF 1.6b | 39x | 37.2x | 6.3x |
| Wed, 19 Apr 2023 | CHF 61.4b | CHF 9.7b | CHF 1.7b | 42.6x | 36.8x | 6.3x |
| Fri, 17 Mar 2023 | CHF 56.6b | CHF 9.7b | CHF 1.7b | 41x | 34.2x | 5.9x |
| Sun, 12 Feb 2023 | CHF 57.2b | CHF 9.6b | CHF 1.6b | 33.2x | 35x | 6x |
| Tue, 10 Jan 2023 | CHF 51.2b | CHF 9.2b | CHF 1.3b | 37.7x | 38.5x | 5.6x |
| Thu, 08 Dec 2022 | CHF 51.3b | CHF 9.2b | CHF 1.3b | 38.2x | 38.6x | 5.6x |
| Sat, 05 Nov 2022 | CHF 50.4b | CHF 9.2b | CHF 1.3b | 39.1x | 37.9x | 5.5x |
Price to Earnings Ratio
37.9x
Current Industry PE
- Investors are relatively neutral on the Swiss Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 45.3x.
- The industry is trading close to its 3-year average PS ratio of 5.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 6.1% per year over the last three years.
- Meanwhile revenues for these companies have grown 5.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare industry?
| CH Market | -1.48% | |
| Healthcare | -4.18% | |
| Life Sciences | 1.97% | |
| Clinical Research and Equipment | 1.97% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| LONN Lonza Group | CHF 570.20 | 2.1% +CHF 828.7m | 5.0% | PE54.6x | |
| BANB Bachem Holding | CHF 58.05 | 6.7% +CHF 273.7m | -17.1% | PE32.4x | |
| PPGN PolyPeptide Group | CHF 25.00 | 4.0% +CHF 31.3m | -13.5% | PS2.4x |
